Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol 3% gel for prevention of radiotherapy-induced dermatitis in breast cancer
IRCT20190425043368N4Phase 3Recruiting
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dermatitis comparing Propranolol 3% gel with Placebo gel (2 arms). Started May 2026; status: recruiting.
02
Drugs
propranolol
03
Conditions
dermatitis
Beyond the preview
Go deeper on IRCT20190425043368N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190425043368N4.